Thank you to all the researchers and health professionals who continue to drive progress in early prostate cancer diagnosis🩵
Your work is helping shape the evidence and care that will save more men’s lives.
Read more about the NSC announcement ➡️bit.ly/4ip3ysp
ALT The photo shows part of an older man with a gray beard, sitting at a laptop.
Stay informed. Support your practice. Improve patient care.
📣 Our clinical update is free, quick to read and built for busy health professionals.
📰 Bringing you the latest in prostate cancer news, resources, CPD and more every month.
Sign up here ➡️ bit.ly/2VktI7b
💻 Prostate Cancer UK Online Learning
Free courses, webinars & resources to build your knowledge and earn self-accredited CPD.
Flexible, practical learning for busy health professionals.
➡️ bit.ly/4rBZDMg#ProstateCancer#CPD
ALT A person sits at a table with an open laptop displaying a video call and a document. They write notes in a notebook. A cup with a hot beverage is nearby.
Stay informed. Support your practice. Improve patient care.
📣 Our clinical update is free, quick to read and built for busy health professionals.
📰 Bringing you the latest in prostate cancer news, resources, CPD and more every month.
Sign up here ➡️ bit.ly/2VktI7b
Join a dedicated space for healthcare professionals to stay informed, connected and supported on prostate cancer care.
Follow our new LinkedIn page for clinical updates, guidance, education & CPD, practical tools and patient info.
Follow now ➡️ bit.ly/4wbdaMO
ALT Three individuals are in a discussion while holding documents. One person, wearing a blue plaid jacket, holds a pink file. Another, dressed in a dark suit, holds a blue folder while gesturing thoughtfully. The third person, in a blue uniform, holds a similar pink file. They appear to be in a professional setting.
Stay informed. Support your practice. Improve patient care.
📣 Our clinical update is free, quick to read and built for busy health professionals.
📰 Bringing you the latest in prostate cancer news, resources, CPD and more every month.
Sign up here ➡️ bit.ly/2VktI7b
Stay informed. Support your practice. Improve patient care.
📣 Our clinical update is free, quick to read and built for busy health professionals.
📰 Bringing you the latest in prostate cancer news, resources, CPD and more every month.
Sign up here ➡️ bit.ly/2VktI7b
💻 Prostate Cancer UK Online Learning
Free courses, webinars & resources to build your knowledge and earn self-accredited CPD.
Flexible, practical learning for busy health professionals.
➡️ bit.ly/4rBZDMg#ProstateCancer#CPD
ALT A person sits at a table with an open laptop displaying a video call and a document. They write notes in a notebook. A cup with a hot beverage is nearby.
📢 Introducing Dr Shaun Scaramuzza, the first of our 2025 Career Acceleration Fellows!
🔬 Shaun’s research aims to improve early detection and treatment options for men at highest risk.
Our 2026 round is still open for applications! You can apply here: bit.ly/3FYMhac
A team led by @susan_heavey at @UCL focuses on making drug development more effective.
Since 2018, we’ve supported her team to use patient‑derived explants & spatial transcriptomics to identify the most promising #ProstateCancer treatments.
📙 Read more: bit.ly/2ADGYs9
Stay informed. Support your practice. Improve patient care.
📣 Our clinical update is free, quick to read and built for busy health professionals.
📰 Bringing you the latest in prostate cancer news, resources, CPD and more every month.
Sign up here ➡️ bit.ly/2VktI7b
ALT Scientific Paper published in The Lancet Oncology, titled: On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials. Written by Kayani et al.
Last chance to apply! Don’t miss this opportunity to secure up to £40k to improve sexual health and wellbeing support for men with advanced prostate cancer. Apply now and make a lasting impact 👉 bit.ly/4efv3EC
Don't miss out! Our joint funding call with Movember supports better pre-treatment counselling, stronger care pathways, and targeted support for those most in need. Help create lasting change in prostate cancer care. Click here to find out more👉 bit.ly/4efv3EC
Strengthening the UK prostate cancer clinical research pipeline.🔬
Our April in‑person CRSG meeting sparked rich discussion on major research proposals & UK‑wide collaboration.
Huge thanks to our proposal presenters, CRSG and Early Career members. 👏
📙bit.ly/4mGKnfK
📚 Update your knowledge and practice
New, free online course on Early Detection in Prostate Cancer in collaboration with @BMJLearning.
Topics include:
🔹Risk
🔹PSA blood testing
🔹Patient referral & more
⭐ Earn 1 CPD point
Start learning ➡️ bit.ly/4ceqGaz
ALT Two medical monitors display MRI scans. The left screen shows a grid of four different cross-sectional images of internal body parts. The right screen focuses on one larger, detailed MRI scan.
Prof Emma Hall supported our Researcher Mentoring Scheme by presenting a Careers in Research webinar, exploring how working with a Clinical Trials and Statistics Unit helps researchers achieve real‑world impact.
The April edition of Research News is here! Read about:
💙 The TRANFORM screening trial.
📢 Our new LinkedIn channel for prostate cancer researchers.
🔬 Research stories with impact.
🏆 Researcher achievements.
💰 Funding opportunities.
Read it here 📰 : bit.ly/4cYOCjE
🥼 Professor Simon Mackay @UniStrathclyde leads a team developing new treatments for men with advanced #ProstateCancer.
💊 In 2019, we funded Simon to further develop his first-in-class IKKα inhibitor.
📙 Read more about Simon's cutting-edge #research: prostatecanceruk.org/researc…
ALT Graphic with a man icon holding a sign reading 'Research We Fund' on the left hand side, a portrait photo of Professor Simon Mackay in the top right corner, and a quote from Simon reading 'Thanks to the funding from Prostate Cancer UK, we have brought this treatment one step closer to clinical trials. After all this time, I'd be over the moon if I could make that difference to men affected by prostate cancer'.